Evidence for an instructive mechanism of de novo methylation in cancer cells

被引:350
作者
Keshet, I [1 ]
Schlesinger, Y
Farkash, S
Rand, E
Hecht, M
Segal, E
Pikarski, E
Young, RA
Niveleau, A
Cedar, H
Simon, I
机构
[1] Hebrew Univ Jerusalem, Dept Cellular Biochem & Human Genet, Jerusalem, Israel
[2] Hebrew Univ Jerusalem, Dept Mol Biol, Jerusalem, Israel
[3] Hebrew Univ Jerusalem, Dept Pathol, Jerusalem, Israel
[4] Rockefeller Univ, Ctr Studies Phys & Biol, New York, NY USA
[5] Whitehead Inst Biomed Res, Cambridge Ctr 9, Cambridge, MA 02142 USA
[6] Univ Grenoble 1, Lab Virol Struct & Mol, La Tronche, France
关键词
D O I
10.1038/ng1719
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
DNA methylation has a role in the regulation of gene expression during normal mammalian development but can also mediate epigenetic silencing of CpG island genes in cancer and other diseases. Many individual genes ( including tumor suppressors) have been shown to undergo de novo methylation in specific tumor types, but the biological logic inherent in this process is not understood. To decipher this mechanism, we have adopted a new approach for detecting CpG island DNA methylation that can be used together with microarray technology. Genome-wide analysis by this technique demonstrated that tumor-specific methylated genes belong to distinct functional categories, have common sequence motifs in their promoters and are found in clusters on chromosomes. In addition, many are already repressed in normal cells. These results are consistent with the hypothesis that cancer-related de novo methylation may come about through an instructive mechanism.
引用
收藏
页码:149 / 153
页数:5
相关论文
共 39 条
[21]   The binding sites for the chromatin insulator protein CTCF map to DNA methylation-free domains genome-wide [J].
Mukhopadhyay, R ;
Yu, WQ ;
Whitehead, J ;
Xu, JW ;
Lezcano, M ;
Pack, S ;
Kanduri, C ;
Kanduri, M ;
Ginjala, V ;
Vostrov, A ;
Quitschke, W ;
Chernukhin, I ;
Klenova, E ;
Lobanenkov, V ;
Ohlsson, R .
GENOME RESEARCH, 2004, 14 (08) :1594-1602
[22]  
Notterman DA, 2001, CANCER RES, V61, P3124
[23]   Control of pancreas and liver gene expression by HNF transcription factors [J].
Odom, DT ;
Zizlsperger, N ;
Gordon, DB ;
Bell, GW ;
Rinaldi, NJ ;
Murray, HL ;
Volkert, TL ;
Schreiber, J ;
Rolfe, PA ;
Gifford, DK ;
Fraenkel, E ;
Bell, GI ;
Young, RA .
SCIENCE, 2004, 303 (5662) :1378-1381
[24]   Role of histone H3 lysine 27 methylation in X inactivation [J].
Plath, K ;
Fang, J ;
Mlynarczyk-Evans, SK ;
Cao, R ;
Worringer, KA ;
Wang, HB ;
de la Cruz, CC ;
Otte, AP ;
Panning, B ;
Zhang, Y .
SCIENCE, 2003, 300 (5616) :131-135
[25]   DNA methylation in health and disease [J].
Robertson, KD ;
Wolffe, AP .
NATURE REVIEWS GENETICS, 2000, 1 (01) :11-19
[26]   Restriction landmark genomic scanning for DNA methylation in cancer: past, present, and future applications [J].
Rush, LJ ;
Plass, C .
ANALYTICAL BIOCHEMISTRY, 2002, 307 (02) :191-201
[27]   Genome-wide discovery of transcriptional modules from DNA sequence and gene expression [J].
Segal, E. ;
Yelensky, R. ;
Koller, D. .
BIOINFORMATICS, 2003, 19 :i273-i282
[28]   Establishment of histone H3 methylation on the inactive X chromosome requires transient recruitment of Eed-Enx1 Polycomb group complexes [J].
Silva, J ;
Mak, W ;
Zvetkova, I ;
Appanah, R ;
Nesterova, TB ;
Webster, Z ;
Peters, AHFM ;
Jenuwein, T ;
Otte, AP ;
Brockdorff, N .
DEVELOPMENTAL CELL, 2003, 4 (04) :481-495
[29]   The study of aberrant methylation in cancer via restriction landmark genomic scanning [J].
Smiraglia, DJ ;
Plass, C .
ONCOGENE, 2002, 21 (35) :5414-5426
[30]   Transcriptional gene silencing promotes DNA hypermethylation through a sequential change in chromatin modifications in cancer cells [J].
Stirzaker, C ;
Song, JZ ;
Davidson, B ;
Clark, SJ .
CANCER RESEARCH, 2004, 64 (11) :3871-3877